Matrine and oxymatrine are two alkaloid compounds found in the Chinese herb Sophora flavescens, also known as Ku Shen. Used for centuries in traditional Chinese medicine, matrine and oxymatrine have recently been the subject of increased scientific research into their potential health benefits. The purpose of this article is to provide an overview of matrine and oxymatrine and explore the current evidence behind their purported effects on conditions such as disease, liver disease, cardiovascular health, respiratory conditions, skin disorders, and more.
Understanding Matrine and Oxymatrine
Matrine and oxymatrine are tetracyclo-quinolizindine alkaloids derived from Ku Shen, a herb commonly used in traditional Chinese medicine. Chemically, matrine and oxymatrine have a similar tetrahydropyridoindole ring structure. The key difference lies in the substituents on the quinolizidine ring system. While matrine contains a methyl group, oxymatrine contains a hydroxyl group. This subtle difference in chemical structure results in some variation in their mechanisms of action and potency.
In traditional Chinese medicine practice, Ku Shen preparations containing matrine and oxymatrine have been utilized to treat fever, edema, arthritis, viral hepatitis, skin inflammations, respiratory infections, dysentery, carbuncles, and sore throat. Modern research has begun investigating whether these historical applications have validity in terms of Matrine Oxymatrine's mechanisms of action and potential health benefits.
Scientific Research on the Effects of Matrine and Oxymatrine
- Liver Disease
The anti-inflammatory, anti-fibrotic, and hepatoprotective properties of matrine and oxymatrine have sparked interest in their potential for treating a variety of liver diseases. Creature exploration and a few primer human preliminaries significantly affect liver capability and side effects in hepatitis B and C, substance poison prompted liver injury, non-alcoholic greasy liver sickness (NAFLD), alcoholic liver illness and liver fibrosis/cirrhosis.
Noticed impacts incorporate restraining viral replication and animating IFN-γ creation in hepatitis, lessening liver protein levels like ALT and AST, weakening oxidative pressure and hepatic stellate cell actuation, obstructing fiery cytokine flagging pathways like TNF-α, IL-6, IL-1β and TGF-β1, decreasing lipid aggregation and fat beads in hepatocytes, advancing mitochondrial capability and hindering extracellular lattice statement and fibrogenesis.
Matrine has exhibited superior antiviral potency compared to oxymatrine in hepatitis models. However, other studies have shown greater anti-inflammatory and antifibrotic effects with oxymatrine. Overall, while larger scale and longer term clinical trials are still needed, the accumulating evidence indicates matrine and oxymatrine's potential value for various types of liver disease, both as monotherapies or adjuvants to standard care.
- Respiratory Conditions
The traditional use of Ku Shen preparations in respiratory ailments has prompted investigation into matrine and oxymatrine for modern respiratory health applications. In vitro studies have demonstrated matrine's ability to suppress airway remodeling by inhibiting airway smooth muscle cell proliferation and migration. Animal models have also shown matrine's potential to attenuate allergic airway inflammation in asthma via modulation of IgE, histamine, IL-4, IL-5, IL-13 and other mediators.
In human trials, matrine supplementation significantly improved symptom scores and lung function in chronic obstructive pulmonary disease (COPD) patients, while oxymatrine reduced cough and asthma exacerbations for bronchial asthma patients. Proposed mechanisms include anti-inflammatory, antioxidant and bronchodilatory effects. While larger scale studies are still needed, the evidence thus far indicates therapeutic potential for matrine and oxymatrine in asthma, COPD, allergies and other lung conditions.
- Skin Disorders
Application of matrine and oxymatrine have also been explored for certain skin disorders with promising indications. Animal research found topical and oral oxymatrine improved symptoms of atopic dermatitis-like skin lesions by downregulating IgE, IL-4 and IL-31 levels along with reducing mast cell degranulation.
In vitro studies also demonstrated anti-fibrotic effects of matrine and oxymatrine on hypertrophic scar fibroblasts, inhibiting cell proliferation, collagen production, and myofibroblast differentiation. In animal hypertrophic scar models, injections of matrine or oxymatrine solutions led to decreased scar elevation index and reduced scar collagen content. These preliminary results warrant further clinical evaluation for matrine/oxymatrine's efficacy in scar prevention/treatment and atopic skin conditions.
- Cardiovascular Health
Some studies have explored Matrine Oxymatrine's effects on cardiovascular health markers, including blood pressure regulation, platelet aggregation, and serum lipid levels. Animal research has shown matrine's ability to relax blood vessels, inhibit angiotensin II and endothelin-1 vasoconstrictive signaling, increase nitric oxide and prostacyclin production and reduce free radical vascular damage – effects that can lower blood pressure.
Human trials have also demonstrated small but significant 3-6 mmHg reductions in systolic and diastolic blood pressure with matrine or oxymatrine treatment in hypertensive patients. Additionally, matrine has been observed to inhibit platelet activation and thrombus formation in arterioles and capillaries via blockade of the P2Y1 and P2Y12 platelet ADP receptors.
When it comes to lipid metabolism, both compounds have exhibited the ability to moderately lower serum triglyceride levels, raise HDL cholesterol and improve the LDL/HDL ratio – effects linked to reduced risk for atherosclerosis and heart disease. These results suggest matrine and oxymatrine may offer protective cardiovascular effects worthy of more thorough clinical evaluation.
- Additional Effects
Along with the above conditions, preliminary evidence suggests matrine and oxymatrine's mechanisms of action may be relevant for other health issues. For example, matrine exhibited antidepressant-like effects comparable to fluoxetine in chronically stressed rat models. Both compounds displayed neuroprotective capabilities in cerebral ischemia models, counteracting neuronal oxidative damage and apoptosis.
Other promising effects seen in animal/cell research include matrine/oxymatrine's ability to alleviate diabetic nephropathy, reduce joint damage in arthritis, protect against aluminum-induced neurotoxicity and bone loss, attenuate alcoholic gastritis and inhibit intestinal inflammation from inflammatory bowel disease. However, these applications require much more extensive future investigation before clinical relevance can be determined.
Practical Applications and Considerations
- Dosage and Duration
Very few clinical studies have examined the optimal therapeutic dosing of matrine and oxymatrine. Animal research indicates dose-dependent responses in some models, with most effects seen using matrine doses between 50-200 mg/kg body weight and oxymatrine doses ranging from 30-360 mg/kg. Most human trials demonstrating benefit have tested oral daily doses of 0.6-1.2g matrine and 0.3-0.6g oxymatrine for 2-24 week treatment durations.
However, pharmacokinetic data suggests rapid clearance occurs within several hours, indicating multiple daily doses may be preferable - although the ideal frequency is unestablished. Given the lack of definitive dosage guidelines, physician-guided use is advised, especially when combining with other medications due to interactions on CYP enzymes and transporters like P-glycoprotein. Starting with lower doses and slowly titrating based on patient tolerance and monitoring is reasonable.
- Potential Toxicity and Side Effects
Gastrointestinal reactions are commonly reported with higher doses of Matrine Oxymatrine use, including diarrhea, abdominal pain, dyspepsia and nausea. Adverse skin reactions like pruritic rash are also possible either with topical use or systemic ingestion. At very high intravenous doses (≥1g/kg) in animal models, oxymatrine administration rapidly induced neurotoxic effects like loss of consciousness and epileptic seizures followed by lethal cardiotoxicity with arrhythmias and cardiac arrest within minutes. However, the acute toxicity data for humans is very limited thus far.
Repeat dose toxicity studies up to 90 days in rodents have shown little toxicity up to matrine doses around 5-10 times typical human oral intake. Nonetheless, caution is still warranted particularly with longer term use, complex health conditions or combination with other drugs/herbals due to the potential for accumulative toxicity or interactions. As always, working closely with a healthcare professional experienced in botanical medicines is advisable for safety.
- Quality Control and Standardization
As matrine and oxymatrine are unregulated herbal supplements, obtaining high quality products from reputable manufacturers following Current Good Manufacturing Practices (CGMPs) is crucial for safety, consistency and efficacy. Contaminants are a huge concern with any herbal product, as well as proper identification and quantification of matrine/oxymatrine content which can vary widely.
Seeking out products standardized to a verified level of matrine and/or oxymatrine is ideal for delivering studied therapeutic amounts. Each company should provide testing data to confirm identity, purity, strength and composition. Consulting an integrative medicine practitioner familiar with evaluating herbal medicine quality is highly recommended when selecting matrine/oxymatrine supplements.
Conclusion
In summary, matrine and oxymatrine demonstrate promising effects in early-stage research on various health conditions like disease, liver disease, respiratory illness, skin disorders, mental health, cardiovascular disease and more. However, clinical evidence is still quite limited and definitive conclusions regarding therapeutic efficacy and safety cannot yet be made.
While historically utilized in traditional Chinese medicine, rigorous further research is essential to validate efficacy and safety of matrine/oxymatrine as modern therapeutic agents or adjuncts. Their quality control issues, unknown optimal dosing, and potential toxicity risks demand cautious yet hopeful investigation.
As research continues to elucidate mechanisms of action, pharmacokinetics, appropriate applications, and ideal standardization - the role of matrine and oxymatrine in evidence-based healthcare may become clearer. For now, working closely with a knowledgeable integrative medicine provider is key for those patients interested in using matrine or oxymatrine dietary supplements. Continued study of these compounds offers much promise at the intersection of traditional and modern medicine.ng matrine or oxymatrine supplements.
Welcome To Send Us Emails If You Are Interested In Matrine Oxymatrine At Sales@Kintaibio.Com.
References:
Zhao, Q., Assimopoulou, A. and Klauck, S., 2015. Matrine: A novel pharmacological agent from traditional Chinese medicine. International journal of molecular sciences, 16(5), pp.9532-9554.
Wang, Y., Yan, Z., Lu, L., He, B., Zhang, L., Liu, H., Shi, H., Zhang, R. and Guo, C., 2021. A review of the antidisease properties and mechanisms of matrine and oxymatrine alkaloids. Biomedicine & Pharmacotherapy, 138, p.111431.
Wu, X., Chen, D. and Xie, G., 2020. The pharmacological effects of matrine and oxymatrine on hepatic fibrosis. Biomedicine & Pharmacotherapy, 121, p.109582.
Liu, Y., Ma, Z., Xiao, W., Li, T., Yin, Z., Geng, H. and Li, Z., 2021. Matrine and Oxymatrine in Respiratory Disease: Therapeutic Potential and Mechanisms. Oxidative medicine and cellular longevity, 2021.
Cheng, R., Li, M., Kang, H., Qin, Z., Quan, S., Liu, Z., Liu, X., Yang, L. and Wang, Z., 2018. Matrine and oxymatrine inhibit migration and TGF-β1-induced EMT in human lung disease cells. Oncology reports, 39(3), pp.1575-1585.
Zhang, Y., Zhang, H., Yu, P., Liu, Q., Liu, K., Duan, H. and Luan, G., 2009. Effects of matrine against the growth of human lung disease and hepatoma cells as well as lung disease cell migration. Cytotechnology, 59(3), pp.191-200.
Zhang, X.Q., Leung, W.S., Cheung, F.K., Cheung, A.H., Yeung, J.H., Jiang, Z.H., Leung, G.P. and Man, R.Y., 2018. Matrine displayed antidepressant effects in mice exposed to chronic unpredictable mild stress: Modulation of oxidative stress and inflammation. Oxidative medicine and cellular longevity, 2018.
